Green Cross Banking On Bioreactors To Develop Biosimilars, Biobetters Faster
This article was originally published in PharmAsia News
Executive Summary
SEOUL - Following a deal late last year to jointly develop biopharmaceutical products through disposable bioreactors, South Korea's vaccine giant Green Cross Corp. is expanding its collaboration to sell PBS Biotech, Inc.'s bioreactors to Korean companies